[HTML][HTML] An overview of PDE4 inhibitors in clinical trials: 2010 to early 2022
L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - Molecules, 2022 - mdpi.com
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
L Crocetti, G Floresta, A Cilibrizzi… - Molecules (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …
[PDF][PDF] An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - Molecules, 2022 - iris.unict.it
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022.
L Crocetti, G Floresta, A Cilibrizzi… - …, 2022 - search.ebscohost.com
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - Molecules, 2022 - kclpure.kcl.ac.uk
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - Molecules, 2022 - cir.nii.ac.jp
抄録< jats: p> Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive
target for the treatment of inflammation-based diseases. Several scientific advancements, by …
target for the treatment of inflammation-based diseases. Several scientific advancements, by …
[HTML][HTML] An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - Molecules, 2022 - ncbi.nlm.nih.gov
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - MOLECULES, 2022 - flore.unifi.it
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …
[PDF][PDF] An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - Molecules, 2022 - academia.edu
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - Molecules, 2022 - search.proquest.com
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …
treatment of inflammation-based diseases. Several scientific advancements, by both …